Satralizumab, previously known as the SA-237 molecule, represents a significant treatment for neuromyelitis optica spectrum disorder and other autoimmune ailments. Recent investigations have demonstrated favorable data regarding its efficacy in reducing relapses and illness progression . Specifically , Phase III examinations – including the ADA… Read More

Anifrolumab, a relatively recent monoclonal antibody, is creating considerable interest within the healthcare community as a possible therapy for various immune-related ailments. This unique medication targets the interferon receptor alpha chain, remarkably reducing tissue damage that drives the development of diseases like SLE and maybe others.… Read More

Apoptosis, also recognized as programmed cell death, plays a vital role in maintaining tissue homeostasis. Dysregulation of apoptosis has been implicated in various pathologies, including cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, modulating apoptotic pathways represents a promising therapeutic strategy for these ai… Read More